These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510 [TBL] [Abstract][Full Text] [Related]
8. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience. Knutsen AP; Wall DA J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237 [TBL] [Abstract][Full Text] [Related]
9. The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901. Dvorak CC; Cowan MJ; Logan BR; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Shearer WT; O'Reilly RJ; Fleisher TA; Pai SY; Hanson IC; Pulsipher MA; Fuleihan R; Filipovich A; Goldman F; Kapoor N; Small T; Smith A; Chan KW; Cuvelier G; Heimall J; Knutsen A; Loechelt B; Moore T; Buckley RH J Clin Immunol; 2013 Oct; 33(7):1156-64. PubMed ID: 23818196 [TBL] [Abstract][Full Text] [Related]
10. Allogeneic Hematopoietic Cell Transplantation in Patients with Primary Immunodeficiencies in Korea: Eleven-Year Experience in a Single Center. Yi ES; Choi YB; Lee NH; Lee JW; Sung KW; Koo HH; Kang ES; Kim YJ; Yoo KH J Clin Immunol; 2018 Oct; 38(7):757-766. PubMed ID: 30151618 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for PIDs: progress, pitfalls and prospects. Mukherjee S; Thrasher AJ Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838 [TBL] [Abstract][Full Text] [Related]
14. Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC. Cuvelier GDE; Logan BR; Prockop SE; Buckley RH; Kuo CY; Griffith LM; Liu X; Yip A; Hershfield MS; Ayoub PG; Moore TB; Dorsey MJ; O'Reilly RJ; Kapoor N; Pai SY; Kapadia M; Ebens CL; Forbes Satter LR; Burroughs LM; Petrovic A; Chellapandian D; Heimall J; Shyr DC; Rayes A; Bednarski JJ; Chandra S; Chandrakasan S; Gillio AP; Madden L; Quigg TC; Caywood EH; Dávila Saldaña BJ; DeSantes K; Eissa H; Goldman FD; Rozmus J; Shah AJ; Vander Lugt MT; Thakar MS; Parrott RE; Martinez C; Leiding JW; Torgerson TR; Pulsipher MA; Notarangelo LD; Cowan MJ; Dvorak CC; Haddad E; Puck JM; Kohn DB Blood; 2022 Aug; 140(7):685-705. PubMed ID: 35671392 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review. de la Morena MT; Nelson RP Clin Rev Allergy Immunol; 2014 Apr; 46(2):131-44. PubMed ID: 23832379 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic cell transplantation for correction of primary immunodeficiencies. Filipovich A Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S49-S52. PubMed ID: 18724301 [TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation for primary immunodeficiency diseases: the North American experience. Pai SY; Cowan MJ Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):521-6. PubMed ID: 25259542 [TBL] [Abstract][Full Text] [Related]